Patent 7122541 was granted and assigned to Rhode Island Hospital on October, 2006 by the United States Patent and Trademark Office.
The invention relates to methods for preventing and treating disseminating cancers. Inhibition metastases of a primary tumor to a liver tissue is carried out by directly contacting a liver tissue with Taurolidine.